+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dofetilide"

Atrial Fibrillation - Pipeline Insight, 2024 - Product Thumbnail Image

Atrial Fibrillation - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Dofetilide is a class III antiarrhythmic drug used to treat atrial fibrillation and atrial flutter. It is a member of the class of drugs known as potassium channel blockers, which work by blocking the flow of potassium ions through the cell membrane. This helps to reduce the rate of electrical conduction in the heart, which can help to reduce the risk of arrhythmia. Dofetilide is used in combination with other drugs to treat atrial fibrillation and atrial flutter, and is also used to prevent recurrence of these conditions. It is available in both oral and intravenous formulations. Dofetilide is a part of the larger cardiovascular drug market, which includes drugs used to treat a variety of conditions related to the heart and blood vessels. These drugs are used to treat conditions such as hypertension, coronary artery disease, and congestive heart failure. The cardiovascular drug market is a large and growing market, with many different types of drugs available. Some companies in the Dofetilide market include Pfizer, Merck, and Sanofi. Show Less Read more